Structure

Physi-Chem Properties

Molecular Weight:  388.15
Volume:  389.179
LogP:  3.637
LogD:  2.961
LogS:  -3.891
# Rotatable Bonds:  6
TPSA:  92.04
# H-Bond Aceptor:  7
# H-Bond Donor:  0
# Rings:  3
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.584
Synthetic Accessibility Score:  3.768
Fsp3:  0.476
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.748
MDCK Permeability:  3.593677683966234e-05
Pgp-inhibitor:  0.989
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.008
20% Bioavailability (F20%):  0.01
30% Bioavailability (F30%):  0.983

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.113
Plasma Protein Binding (PPB):  88.65940856933594%
Volume Distribution (VD):  1.422
Pgp-substrate:  14.722015380859375%

ADMET: Metabolism

CYP1A2-inhibitor:  0.663
CYP1A2-substrate:  0.391
CYP2C19-inhibitor:  0.645
CYP2C19-substrate:  0.17
CYP2C9-inhibitor:  0.678
CYP2C9-substrate:  0.126
CYP2D6-inhibitor:  0.535
CYP2D6-substrate:  0.138
CYP3A4-inhibitor:  0.74
CYP3A4-substrate:  0.388

ADMET: Excretion

Clearance (CL):  2.577
Half-life (T1/2):  0.291

ADMET: Toxicity

hERG Blockers:  0.012
Human Hepatotoxicity (H-HT):  0.982
Drug-inuced Liver Injury (DILI):  0.948
AMES Toxicity:  0.162
Rat Oral Acute Toxicity:  0.074
Maximum Recommended Daily Dose:  0.035
Skin Sensitization:  0.102
Carcinogencity:  0.496
Eye Corrosion:  0.003
Eye Irritation:  0.017
Respiratory Toxicity:  0.241

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC476455

Natural Product ID:  NPC476455
Common Name*:   [(9R,10R)-9-Acetyloxy-8,8-Dimethyl-2-Oxo-9,10-Dihydropyrano[2,3-F]Chromen-10-Yl] 2-Methylbutanoate
IUPAC Name:   [(9R,10R)-9-acetyloxy-8,8-dimethyl-2-oxo-9,10-dihydropyrano[2,3-f]chromen-10-yl] 2-methylbutanoate
Synonyms:  
Standard InCHIKey:  CVCGZZMJIGSWHX-CDDDFZJFSA-N
Standard InCHI:  InChI=1S/C21H24O7/c1-6-11(2)20(24)27-18-16-14(28-21(4,5)19(18)25-12(3)22)9-7-13-8-10-15(23)26-17(13)16/h7-11,18-19H,6H2,1-5H3/t11?,18-,19-/m1/s1
SMILES:  CCC(C(=O)O[C@@H]1c2c(ccc3c2oc(=O)cc3)OC([C@@H]1OC(=O)C)(C)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL68513
PubChem CID:   10068841
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000145] Coumarins and derivatives
        • [CHEMONTID:0003484] Pyranocoumarins
          • [CHEMONTID:0003485] Angular pyranocoumarins

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO3509 Angelica furcijuga Species Apiaceae Eukaryota roots Miyazaki prefecture, Japan n.a. PMID[9873511]
NPO3509 Angelica furcijuga Species Apiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO3509 Angelica furcijuga Species Apiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO3509 Angelica furcijuga Species Apiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT29 Organism Rattus norvegicus Rattus norvegicus IC50 > 100000.0 nM PMID[559289]
NPT29 Organism Rattus norvegicus Rattus norvegicus Inhibition = -2.5 % PMID[559289]
NPT32 Organism Mus musculus Mus musculus IC50 = 8200.0 nM PMID[559289]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC476455 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC55615
1.0 High Similarity NPC149320
1.0 High Similarity NPC160727
1.0 High Similarity NPC128529
1.0 High Similarity NPC177281
1.0 High Similarity NPC471630
1.0 High Similarity NPC283019
0.9922 High Similarity NPC86892
0.9922 High Similarity NPC471909
0.9922 High Similarity NPC472424
0.9922 High Similarity NPC471625
0.9922 High Similarity NPC281241
0.9845 High Similarity NPC18804
0.9845 High Similarity NPC260265
0.9845 High Similarity NPC198381
0.9845 High Similarity NPC287182
0.9845 High Similarity NPC164269
0.9845 High Similarity NPC127888
0.9845 High Similarity NPC74655
0.9845 High Similarity NPC195343
0.9845 High Similarity NPC84894
0.9845 High Similarity NPC319859
0.9845 High Similarity NPC166672
0.9845 High Similarity NPC100986
0.9845 High Similarity NPC47163
0.9845 High Similarity NPC267412
0.9767 High Similarity NPC167111
0.9767 High Similarity NPC296624
0.9767 High Similarity NPC471910
0.9767 High Similarity NPC133956
0.9767 High Similarity NPC207002
0.9767 High Similarity NPC318400
0.9552 High Similarity NPC287286
0.9549 High Similarity NPC211110
0.9542 High Similarity NPC307412
0.9542 High Similarity NPC55149
0.9478 High Similarity NPC312881
0.9466 High Similarity NPC222036
0.9466 High Similarity NPC7526
0.9412 High Similarity NPC119640
0.9412 High Similarity NPC183646
0.9407 High Similarity NPC195357
0.9407 High Similarity NPC152771
0.9403 High Similarity NPC279573
0.9398 High Similarity NPC283331
0.9389 High Similarity NPC14248
0.9343 High Similarity NPC476457
0.9328 High Similarity NPC153818
0.9328 High Similarity NPC155963
0.9328 High Similarity NPC232246
0.9323 High Similarity NPC469675
0.9259 High Similarity NPC151946
0.9254 High Similarity NPC224543
0.9254 High Similarity NPC78746
0.9254 High Similarity NPC188380
0.9237 High Similarity NPC80170
0.9225 High Similarity NPC471826
0.9185 High Similarity NPC225106
0.9185 High Similarity NPC294456
0.9185 High Similarity NPC212124
0.9185 High Similarity NPC184861
0.9185 High Similarity NPC281014
0.9179 High Similarity NPC472525
0.916 High Similarity NPC168710
0.9147 High Similarity NPC471828
0.9147 High Similarity NPC471827
0.9137 High Similarity NPC469701
0.9111 High Similarity NPC38099
0.9111 High Similarity NPC26954
0.9104 High Similarity NPC224475
0.9104 High Similarity NPC213173
0.9104 High Similarity NPC62366
0.9104 High Similarity NPC180716
0.9084 High Similarity NPC60704
0.9084 High Similarity NPC139595
0.9084 High Similarity NPC293642
0.9084 High Similarity NPC199204
0.9084 High Similarity NPC472519
0.907 High Similarity NPC201667
0.907 High Similarity NPC73413
0.907 High Similarity NPC111347
0.907 High Similarity NPC27671
0.9037 High Similarity NPC33986
0.903 High Similarity NPC31849
0.903 High Similarity NPC469955
0.903 High Similarity NPC469952
0.9 High Similarity NPC85624
0.8992 High Similarity NPC273772
0.8992 High Similarity NPC472518
0.8992 High Similarity NPC109675
0.8978 High Similarity NPC270256
0.8963 High Similarity NPC326600
0.8963 High Similarity NPC50896
0.8963 High Similarity NPC204353
0.8963 High Similarity NPC98179
0.8963 High Similarity NPC253574
0.8939 High Similarity NPC185066
0.8939 High Similarity NPC157212
0.8936 High Similarity NPC294365
0.8936 High Similarity NPC171656
0.8931 High Similarity NPC188327
0.8931 High Similarity NPC234109
0.8929 High Similarity NPC471824
0.8923 High Similarity NPC291899
0.8915 High Similarity NPC96286
0.8915 High Similarity NPC248429
0.8905 High Similarity NPC471069
0.8905 High Similarity NPC471068
0.8889 High Similarity NPC55147
0.8889 High Similarity NPC54503
0.8881 High Similarity NPC29734
0.8873 High Similarity NPC87950
0.8873 High Similarity NPC296377
0.8873 High Similarity NPC471764
0.8849 High Similarity NPC472523
0.8846 High Similarity NPC50720
0.8846 High Similarity NPC173350
0.8846 High Similarity NPC290605
0.8846 High Similarity NPC154176
0.8841 High Similarity NPC307883
0.8841 High Similarity NPC471071
0.8841 High Similarity NPC471072
0.8841 High Similarity NPC471070
0.8819 High Similarity NPC103116
0.8815 High Similarity NPC194277
0.8815 High Similarity NPC469956
0.8815 High Similarity NPC19157
0.8811 High Similarity NPC169510
0.8806 High Similarity NPC113098
0.8769 High Similarity NPC13007
0.8769 High Similarity NPC257188
0.8769 High Similarity NPC150214
0.8768 High Similarity NPC306365
0.8768 High Similarity NPC14697
0.876 High Similarity NPC180006
0.876 High Similarity NPC163200
0.876 High Similarity NPC235190
0.875 High Similarity NPC205797
0.875 High Similarity NPC1220
0.875 High Similarity NPC141822
0.875 High Similarity NPC163557
0.875 High Similarity NPC469449
0.875 High Similarity NPC142563
0.875 High Similarity NPC241165
0.875 High Similarity NPC469965
0.875 High Similarity NPC291551
0.8741 High Similarity NPC272650
0.8741 High Similarity NPC267336
0.8732 High Similarity NPC76657
0.8732 High Similarity NPC295696
0.8722 High Similarity NPC289316
0.8714 High Similarity NPC155552
0.8705 High Similarity NPC37428
0.8705 High Similarity NPC144512
0.8705 High Similarity NPC47040
0.8705 High Similarity NPC35501
0.8705 High Similarity NPC278600
0.8705 High Similarity NPC137262
0.8702 High Similarity NPC315807
0.8696 High Similarity NPC104796
0.8696 High Similarity NPC167517
0.8692 High Similarity NPC144418
0.869 High Similarity NPC164299
0.8686 High Similarity NPC309953
0.8686 High Similarity NPC131950
0.8676 High Similarity NPC175159
0.8676 High Similarity NPC123954
0.8667 High Similarity NPC19242
0.8647 High Similarity NPC163248
0.8633 High Similarity NPC131198
0.863 High Similarity NPC180351
0.8623 High Similarity NPC311430
0.8623 High Similarity NPC229128
0.8623 High Similarity NPC224941
0.8613 High Similarity NPC36437
0.8613 High Similarity NPC241341
0.8613 High Similarity NPC472522
0.8613 High Similarity NPC233018
0.8605 High Similarity NPC281356
0.8605 High Similarity NPC298796
0.8603 High Similarity NPC472517
0.8601 High Similarity NPC475719
0.8601 High Similarity NPC101255
0.8601 High Similarity NPC43716
0.8592 High Similarity NPC229916
0.8582 High Similarity NPC258567
0.8582 High Similarity NPC243688
0.8582 High Similarity NPC138149
0.8582 High Similarity NPC183642
0.8582 High Similarity NPC121740
0.8582 High Similarity NPC310370
0.8582 High Similarity NPC224774
0.8571 High Similarity NPC232692
0.8571 High Similarity NPC202594
0.8561 High Similarity NPC143725
0.8561 High Similarity NPC286843
0.8551 High Similarity NPC147030
0.854 High Similarity NPC137669
0.854 High Similarity NPC319969
0.8531 High Similarity NPC471763

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC476455 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.875 High Similarity NPD5123 Clinical (unspecified phase)
0.875 High Similarity NPD5124 Phase 1
0.8322 Intermediate Similarity NPD1652 Phase 2
0.8212 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8134 Intermediate Similarity NPD422 Phase 1
0.8112 Intermediate Similarity NPD2796 Approved
0.8052 Intermediate Similarity NPD7075 Discontinued
0.8042 Intermediate Similarity NPD3748 Approved
0.8026 Intermediate Similarity NPD6801 Discontinued
0.8014 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD1296 Phase 2
0.8 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7986 Intermediate Similarity NPD1008 Clinical (unspecified phase)
0.7933 Intermediate Similarity NPD920 Approved
0.7895 Intermediate Similarity NPD4380 Phase 2
0.7881 Intermediate Similarity NPD1653 Approved
0.7877 Intermediate Similarity NPD2424 Discontinued
0.7857 Intermediate Similarity NPD4908 Phase 1
0.7857 Intermediate Similarity NPD7819 Suspended
0.7852 Intermediate Similarity NPD6799 Approved
0.7847 Intermediate Similarity NPD7097 Phase 1
0.7843 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7843 Intermediate Similarity NPD7411 Suspended
0.7834 Intermediate Similarity NPD5494 Approved
0.7826 Intermediate Similarity NPD5844 Phase 1
0.7823 Intermediate Similarity NPD1243 Approved
0.78 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.78 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7785 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.777 Intermediate Similarity NPD3266 Approved
0.777 Intermediate Similarity NPD3267 Approved
0.777 Intermediate Similarity NPD3750 Approved
0.777 Intermediate Similarity NPD2797 Approved
0.7756 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7748 Intermediate Similarity NPD7314 Clinical (unspecified phase)
0.7742 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7737 Intermediate Similarity NPD1610 Phase 2
0.7707 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7703 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD5403 Approved
0.7692 Intermediate Similarity NPD3817 Phase 2
0.7682 Intermediate Similarity NPD5401 Approved
0.7674 Intermediate Similarity NPD1358 Approved
0.7662 Intermediate Similarity NPD6599 Discontinued
0.7658 Intermediate Similarity NPD919 Approved
0.7652 Intermediate Similarity NPD5535 Approved
0.7647 Intermediate Similarity NPD5691 Approved
0.7643 Intermediate Similarity NPD7768 Phase 2
0.7639 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7639 Intermediate Similarity NPD1613 Approved
0.7639 Intermediate Similarity NPD4307 Phase 2
0.7635 Intermediate Similarity NPD1549 Phase 2
0.7622 Intermediate Similarity NPD3268 Approved
0.7622 Intermediate Similarity NPD6798 Discontinued
0.7606 Intermediate Similarity NPD6832 Phase 2
0.7597 Intermediate Similarity NPD8158 Clinical (unspecified phase)
0.7597 Intermediate Similarity NPD3134 Approved
0.7586 Intermediate Similarity NPD6355 Discontinued
0.758 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.758 Intermediate Similarity NPD5402 Approved
0.7574 Intermediate Similarity NPD1548 Phase 1
0.7571 Intermediate Similarity NPD3225 Approved
0.7568 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7568 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7566 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7564 Intermediate Similarity NPD1934 Approved
0.7551 Intermediate Similarity NPD7033 Discontinued
0.7533 Intermediate Similarity NPD4628 Phase 3
0.7519 Intermediate Similarity NPD9697 Approved
0.7517 Intermediate Similarity NPD4060 Phase 1
0.75 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD4749 Approved
0.75 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.747 Intermediate Similarity NPD6559 Discontinued
0.745 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.745 Intermediate Similarity NPD6002 Phase 3
0.745 Intermediate Similarity NPD6005 Phase 3
0.745 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.745 Intermediate Similarity NPD6004 Phase 3
0.7448 Intermediate Similarity NPD6233 Phase 2
0.7447 Intermediate Similarity NPD8651 Approved
0.7432 Intermediate Similarity NPD2799 Discontinued
0.7432 Intermediate Similarity NPD1510 Phase 2
0.7432 Intermediate Similarity NPD4308 Phase 3
0.7431 Intermediate Similarity NPD4625 Phase 3
0.7425 Intermediate Similarity NPD7549 Discontinued
0.7423 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7413 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD3496 Discontinued
0.7405 Intermediate Similarity NPD8455 Phase 2
0.74 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7386 Intermediate Similarity NPD7837 Clinical (unspecified phase)
0.7383 Intermediate Similarity NPD2935 Discontinued
0.7383 Intermediate Similarity NPD1551 Phase 2
0.7379 Intermediate Similarity NPD2313 Discontinued
0.7357 Intermediate Similarity NPD1091 Approved
0.7355 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7347 Intermediate Similarity NPD4340 Discontinued
0.7347 Intermediate Similarity NPD1933 Approved
0.7347 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7343 Intermediate Similarity NPD1019 Discontinued
0.7342 Intermediate Similarity NPD37 Approved
0.7338 Intermediate Similarity NPD4626 Approved
0.7333 Intermediate Similarity NPD1241 Discontinued
0.7312 Intermediate Similarity NPD4966 Approved
0.7312 Intermediate Similarity NPD4967 Phase 2
0.7312 Intermediate Similarity NPD4965 Approved
0.731 Intermediate Similarity NPD7095 Approved
0.731 Intermediate Similarity NPD3027 Phase 3
0.7303 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7301 Intermediate Similarity NPD7229 Phase 3
0.7296 Intermediate Similarity NPD2801 Approved
0.7292 Intermediate Similarity NPD2861 Phase 2
0.7267 Intermediate Similarity NPD3749 Approved
0.7267 Intermediate Similarity NPD2438 Suspended
0.7267 Intermediate Similarity NPD6100 Approved
0.7267 Intermediate Similarity NPD6099 Approved
0.7266 Intermediate Similarity NPD5585 Approved
0.7261 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.726 Intermediate Similarity NPD7985 Registered
0.725 Intermediate Similarity NPD5353 Approved
0.725 Intermediate Similarity NPD2415 Discontinued
0.7248 Intermediate Similarity NPD4536 Approved
0.7248 Intermediate Similarity NPD4538 Approved
0.7248 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7239 Intermediate Similarity NPD8127 Discontinued
0.7239 Intermediate Similarity NPD7199 Phase 2
0.7239 Intermediate Similarity NPD1247 Approved
0.7237 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7234 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7234 Intermediate Similarity NPD1611 Approved
0.7229 Intermediate Similarity NPD3818 Discontinued
0.7226 Intermediate Similarity NPD2533 Approved
0.7226 Intermediate Similarity NPD2534 Approved
0.7226 Intermediate Similarity NPD2532 Approved
0.7226 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD6234 Discontinued
0.7219 Intermediate Similarity NPD5763 Approved
0.7219 Intermediate Similarity NPD5762 Approved
0.7218 Intermediate Similarity NPD2684 Approved
0.7214 Intermediate Similarity NPD1778 Approved
0.7214 Intermediate Similarity NPD17 Approved
0.7212 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD6166 Phase 2
0.7212 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD6667 Approved
0.7208 Intermediate Similarity NPD5058 Phase 3
0.7208 Intermediate Similarity NPD6666 Approved
0.7202 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7195 Intermediate Similarity NPD6232 Discontinued
0.719 Intermediate Similarity NPD7466 Approved
0.7188 Intermediate Similarity NPD1465 Phase 2
0.7186 Intermediate Similarity NPD7054 Approved
0.7183 Intermediate Similarity NPD9717 Approved
0.7179 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD7473 Discontinued
0.7162 Intermediate Similarity NPD4140 Approved
0.7162 Intermediate Similarity NPD1240 Approved
0.7162 Intermediate Similarity NPD2979 Phase 3
0.7161 Intermediate Similarity NPD1511 Approved
0.7152 Intermediate Similarity NPD6032 Approved
0.7152 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD4288 Approved
0.7143 Intermediate Similarity NPD3887 Approved
0.7143 Intermediate Similarity NPD7074 Phase 3
0.7143 Intermediate Similarity NPD7472 Approved
0.7134 Intermediate Similarity NPD6959 Discontinued
0.7132 Intermediate Similarity NPD7843 Approved
0.7122 Intermediate Similarity NPD5536 Phase 2
0.7122 Intermediate Similarity NPD7644 Approved
0.7118 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7114 Intermediate Similarity NPD4618 Approved
0.7114 Intermediate Similarity NPD4622 Approved
0.7114 Intermediate Similarity NPD447 Suspended
0.7108 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD2346 Discontinued
0.7101 Intermediate Similarity NPD7157 Approved
0.7101 Intermediate Similarity NPD6797 Phase 2
0.7099 Intermediate Similarity NPD3882 Suspended
0.7097 Intermediate Similarity NPD6652 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD8032 Phase 2
0.7095 Intermediate Similarity NPD4062 Phase 3
0.7086 Intermediate Similarity NPD5588 Approved
0.7086 Intermediate Similarity NPD5960 Phase 3
0.707 Intermediate Similarity NPD1512 Approved
0.707 Intermediate Similarity NPD6273 Approved
0.7067 Intermediate Similarity NPD6653 Approved
0.7067 Intermediate Similarity NPD1607 Approved
0.7063 Intermediate Similarity NPD1608 Approved
0.7059 Intermediate Similarity NPD2897 Discontinued
0.7059 Intermediate Similarity NPD7251 Discontinued
0.7055 Intermediate Similarity NPD3018 Phase 2
0.7051 Intermediate Similarity NPD7213 Phase 3
0.7051 Intermediate Similarity NPD7212 Phase 2
0.7044 Intermediate Similarity NPD7458 Discontinued
0.7044 Intermediate Similarity NPD3226 Approved
0.7039 Intermediate Similarity NPD4477 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data